Drug manufacturer SCM Pharma is one of only 20 firms across the UK – and the only one from the North East – that is attending the week-long UK Trade & Investment (UKTI) Bio and Pharma trade mission to Japan this month.
The Prudhoe-based firm’s managing director Dianne Sharp will be representing the company and will present to delegates at the British Embassy in Tokyo, and an additional seminar in Osaka.
With the assistance of the UKTI team in Japan, Mrs Sharp is also scheduled to meet several Japanese firms with a view to generating interest in the SCM Pharma’s niche sterile filling services.
She said: “We have had an increasing number of enquiries from Japanese pharmaceutical and biotech firms over the last year, so the opportunity to promote our services as part of such a prestigious trade mission is an ideal one.
“This, I expect, is the first step in generating significant revenue from the Japanese pharmaceutical market over the next few years.”
SCM Pharma’s global push, which has seen it secure contracts in the US and Europe, has been assisted by a UKTI grant awarded early this year to help support its export growth. The firm was one of only 40 businesses in the region to be successful in winning the £30,000 UKTI Horizons grant.
Keith Stockdale, UKTI’s international trade adviser, said: “UKTI has worked closely with SCM Pharma to promote its innovative products in overseas markets, and the company will be a wonderful ambassador for the North East in helping showcase what the region has to offer.”
With around 50 employees, SCM Pharma provides sterile and non-sterile production services to assist clients progressing innovative drug products through clinical trials.
With an emphasis on novel, difficult and dangerous products, it also makes drugs for customers that require low volume commercial supply of niche licensed products.
The company has now worked with a third of the top 10 global pharmaceutical firms on various product indications.